SCHEMBL2229112

SCHEMBL2229112

O=C(OCc1cscn1)N1CCC(CCOc2ccc(Cl)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.43
FAAH O00519 2/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
TEAD1 P28347 1/20 0.42
TEAD3 Q99594 1/20 0.42
GPR119 Q8TDV5 6/20 0.42
HRH2 P25021 1/20 0.41
HRH1 P35367 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
ENPP2 Q13822 2/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
GAA P10253 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38
CHEK2 O96017 1/20 0.38
CHRM4 P08173 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2228850 0.90 GRIN2B (0.46) MEN1KMT2ATEAD1TEAD3GPR119
SCHEMBL2228891 0.88 TEAD1 (0.50) FAAHTEAD1TEAD3GPR119MMP2
SCHEMBL2226384 0.88 HRH3 (0.43) TEAD1TEAD3GPR119HRH2HRH1
SCHEMBL2365458 0.88 LIPE (0.43) FAAHHPGDTEAD1TEAD3GPR119
SCHEMBL2231117 0.88 TEAD1 (0.47) FAAHTEAD1TEAD3GPR119HRH2
SCHEMBL2229119 0.87 GRM5 (0.47) GRM5FAAHMEN1ALDH1A1LMNA
SCHEMBL13837204 0.87 GRIN2B (0.43) MEN1LMNAKMT2ATEAD1TEAD3
SCHEMBL2230451 0.87 CHRM4 (0.43) FAAHTEAD1TEAD3GPR119MMP2
SCHEMBL2363762 0.87 GPR119 (0.47) HPGDTEAD1TEAD3GPR119HRH2
SCHEMBL27884721 0.87 MMP2 (0.43) GRM5MEN1ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US claimed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP claimed
CN-102803258-A Alkyl-heterocyclic carbamate derivatives, their preparation and therapeutic use SANOFI AVENTIS 2012-11-28 CN claimed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US claimed
WO-2011089550-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2011-07-28 WO claimed
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US disclosed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP disclosed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION PRMT9, PRMT8, CBR1 GRM5 124/4885FAAH 1562/4885MEN1 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.